Actinium Pharmaceuticals Inc (ATNM) — Free Cash Flow Generation Index

Latest as of June 2022: 0.99x

Actinium Pharmaceuticals Inc (ATNM) has a Free Cash Flow Generation Index of 0.99x as of June 2022. Free cash flow of $27.65 Million represents 1% of operating cash flow ($27.92 Million). Read ATNM current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$27.65 Million
USD

Operating Cash Flow

$27.92 Million
USD

Capital Expenditures

$270.00K
USD

Actinium Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2022)

Historical FCF Generation Index trend for Actinium Pharmaceuticals Inc across 3 annual periods. Explore how much does Actinium Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Actinium Pharmaceuticals Inc (2010–2022)

Year-by-year Free Cash Flow Generation Index for Actinium Pharmaceuticals Inc. For the full company profile including market capitalisation, see ATNM stock market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.96x $8.28 Million $8.64 Million $366.00K ▼ -4.2%
2011 1.00x $539.00 $539.00 $0.00 ▲ +0.0%
2010 1.00x $7.83K $7.83K $0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).